0001567619-18-003298.txt : 20181001 0001567619-18-003298.hdr.sgml : 20181001 ACCESSION NUMBER: 0001567619-18-003298 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181001 DATE AS OF CHANGE: 20181001 EFFECTIVENESS DATE: 20181001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KSQ Therapeutics, Inc. CENTRAL INDEX KEY: 0001754052 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-322472 FILM NUMBER: 181096187 BUSINESS ADDRESS: STREET 1: 610 MAIN STREET NORTH STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-674-9150 MAIL ADDRESS: STREET 1: 610 MAIN STREET NORTH STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001754052 KSQ Therapeutics, Inc. 610 MAIN STREET NORTH 4TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02139 617-674-9150 DELAWARE None None Corporation true 2015 DAVID P. MEEKER, M.D. 610 MAIN STREET NORTH 4TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02139 Executive Officer Director PRESIDENT AND CHIEF EXECUTIVE OFFICER JOHN TRZUPEK, PH.D. 610 MAIN STREET NORTH 4TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02139 Executive Officer TREASURER, SECRETARY & CHIEF FINANCIAL OFFICER FRANK STEGMEIER, PH.D. 610 MAIN STREET NORTH 4TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02139 Executive Officer CHIEF SCIENTIFIC OFFICER DAVID A. BERRY, M.D., PH.D. 610 MAIN STREET NORTH 4TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02139 Director ALAN L. CRANE 610 MAIN STREET NORTH 4TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02139 Director JAMES GILBERT 610 MAIN STREET NORTH 4TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02139 Director GEORGE GOLUMBESKI 610 MAIN STREET NORTH 4TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02139 Director RICHARD A. MOSCICKI, PH.D. 610 MAIN STREET NORTH 4TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02139 Director Pharmaceuticals Decline to Disclose 06b false 2018-09-17 false true false 0 80599985 80599985 0 false 16 0 0 0 false KSQ Therapeutics, Inc. /S/ JOHN TRZUPEK, PH.D. JOHN TRZUPEK, PH.D. CHIEF FINANCIAL OFFICER 2018-10-01